Welcome The yet2.com global technology marketplace lists intellectual property, technology, and patents for technology transfer, technology licensing, patent licensing and patent sale. As premier technology brokers, yet2.com offers this essential IP marketplace for technology owners, technology seekers, and technology brokers interested in technology acquisition, patent licensing, intellectual property licensing (IP licensing), and intellectual property transfer.   more...  Interested? This is an abstract of a technology that is available for sale or license. yet2.com can introduce you confidentially to the owner of this technology. To view the complete TechPak, please register with us.  Still looking? Enter a keyword or phrase below, and search now to find other technologies of interest.		TechPak Categories Cyclic Glycerophosphates and their Analogs Promote Neural Cells Differentiation and Neural Activity. Cyclic glycerophosphates and analogs thereof (CGs) are shown to exert neutral promoting activities in target cells. Such activities include promotion of neuronal outgrowth, promotion of nerve growth, provision of dopaminotrophic supporting envrionment in a diseased portion of the brain, prevention of nerve degeneration and nerve rescue. These activities of the CGs render them useful for treatment of various disorders including but not limited to mental disorders such as, for example, schizophrenia, dementia or disorders resulting in learning disablities. In addition, these CGs may be used for the treatment of neurodegenerative conditions such as Altzheimer's diesease, Parkinson's disease, conditions resulting from exposure to harmful environmental factors or resulting from a mechanical injury. The CGs may also be used to treat an individual suffering from a primary neurodengenerative condition in order to prevent or reduce the appearance of secondary degeneration in additional nerves (“nerve rescue”).pharmaceutical composition prevention treatment disorders diseases prevented treated promoting neural cell differentiation and/or activity mental schizophrenia dementia learning disabilities Interested? This is an abstract of a technology that is available for sale or license. yet2.com can introduce you confidentially to the owner of this technology. To view the complete TechPak, please register with us.
yet2.com TechPakTM produced by yet2.com. For an introduction to the owner of this technology please visit www.yet2.com or call:
Boston, MA, USA + 1 (781) 972-0600 fax + 1 (781) 972-0601 Hertfordshire, United Kingdom + 44 (0) 1923 285282 fax + 44 (0) 1923 285280 Tokyo, Japan + 81-3-5157-5440 fax + 81-3-5157-5441 Copyright © 1999-2008 by yet2.com, Inc. All Rights Reserved.